NanoViricides (NYSE-A:NNVC), a clinical-stage developer of broad-spectrum antiviral drugs, announced it will present today, November 3, 2025, at 9:45 a.m. ET during the Spartan Capital Investor Conference in New York City.
President and Executive Chairman Dr. Anil Diwan will provide updates on the company, its drug pipeline, and platform technologies available for licensing.